Summary. In this paper, we consider comparing the areas under correlated receiver operating characteristic (ROC) curves of diagnostic biomarkers whose measurements are subject to a limit of detection (LOD), a source of measurement error from instruments' sensitivity in epidemiological studies.
Introduction
Receiver operating characteristic (ROC) curve is a well accepted statistical tool for evaluating the discriminatory ability of biomarkers (e.g., Shapiro, 1999 ). An ROC curve plots the true positive rates of a biomarker versus its false positive rates for various thresholds of the test result. It is a convenient way to compare diagnostic biomarkers since the ROC curve places tests on the same scale where they can be compared for accuracy.
The area under the ROC curve (AUC) is a common index of the diagnostic performance of a biomarker. Bamber (1975) showed that AUC = Pr(X > Y), where X and Y represent values of the biomarker from diseased and healthy populations, respectively. Obviously, the closer the AUC is to one, the better the diagnostic accuracy of the biomarker. In a parametric setting the AUCs can generally be expressed as a function of unknown parameters and thus can be evaluated via estimation of these parameters. Nonparametric estimation of the AUC has also been well addressed in the biostatistical and epidemiological literature. However, the test-scores of biomarkers are frequently associated with measurement error, and in this paper we focus on measurement errors due to the limit of detection (LOD).
The LOD is a source of bias in many experiments and is usually caused by the limitation of instruments in measuring very high or low concentrations (e.g., Lyles et al, 2001; Lubin et al, 2004; Schisterman et al, 2006; Vexler et al, 2006; Mumford et al, 2006) . This inability to accurately determine values of biomarkers introduces bias in the analysis of data from such experiments. For example, biomarkers for polychlorinated biphenyl (PCB), which are associated with endometriosis (Louis et al, 2005) , are limited by instrument sensitivity (e.g., Lubin et al, 2004) . The LOD issue can be considered as a problem of censored data analysis (e.g., Vexler et al, 2006) . Perkins et al. (2006) as well as Mumford et al. (2006) have proposed methods for estimation of ROC curves based on samples with LOD.
Often it is necessary to determine whether a biomarker has satisfactory accuracy in correctly discriminating between cases and controls, e.g. testing for AU C = 0.5 (i.e. a biomarker has no discriminatory ability), or whether one biomarker has better diagnostic accuracy than another (e.g., Molodianovitch et al, 2006) . This can be achieved by comparing the AUCs of these biomarkers. The present paper addresses these issues when the measurements of the biomarkers are subject to a limit of detection. We investigate the maximum likelihood ratio test (MLRT), utilizing the likelihood function proposed by Lyles et al. (2001) . Operating characteristics of the proposed tests (e.g. significance level and power) can be obtained from classical results of the maximum likelihood method.
The paper is organized as follows. Section 2 introduces the MLRT for comparing AUCs. Section 3 presents Monte Carlo simulation results. In section 4, we apply the proposed tests to data from two studies to evaluate the AUCs of several biomarkers, with some concluding remarks in section 5. One example is from a study conducted in Birmingham, Alabama to investigate whether intrauterine inflammation is associated with neuron developmental abnormalities in early childhood, so that certain educational methods for improvement will be utilized. In this example the levels of intrauterine inflammation biomarkers are observed only if they are above the detection limits. Another example uses data from a study of atherosclerotic coronary heart disease to test for discriminatory ability of several biomarkers. This study sampled residents of Niagara and Erie counties in New York who were between the ages of 35 and 79. Adults between the ages of 35 and 65 were randomly selected using the New York State Department of Motor Vehicles drivers' licenses rolls. Individuals between 65 and 79 years of age were sampled randomly from the Health Care Financing Administration database. A cohort of 942 individuals consisted of 143 people with myocardial infarction (cases) and 799 controls. The purpose of the study was to determine whether biomarkers that measure individuals' oxidative stress and antioxidant status are good at determining an individual's disease status.
Maximum Likelihood Ratio Tests

Test Based on Complete Data
Let X k and Y k represent the values of biomarker k(= 1, 2) associated with a diseased (X) and healthy (Y ) population, respectively, and {x k1 , . . . , x kn } and {y k1 , . . . , y km } be the corresponding test-scores. Suppose the indepen-
and similarly,
Following Bamber (1975) , the AUCs of the biomarkers are AU C 1 = P (X 1 > Y 1 ) and AU C 2 = P (X 2 > Y 2 ), respectively.
In this section, we formally consider testing hypothesis
It is clear that
, and therefore
In a simple case, where all the parameters are known and there is no measurement error, i.e. (X 1 , X 2 ) and (Y 1 , Y 2 ) are observed completely, we can utilize the classical maximum likelihood ratio test for testing H 0 . To this
Thus, we reject the null hypothesis iff z > z α , where the threshold z α corresponds to Type I error α. It is clear that this test is the most powerful unbiased test; see e.g. Lehmann (1997) .
When the parameters Θ Molodianovitch et al. (2006) propose the transformed normal approach by normalizing data through transformation and then applying the parametric test proposed by Wieand et al. (1989) in order to test for hypothesis (1) . (This test is based on confidence intervals of AUCs (e.g., Reiser and Faraggi, 1997). We will investigate this method in detail in Section 4.2.) Alternatively, we can apply the maximum likelihood estimation and obtain the test-statistic
It is well known (e.g., Lehmann, 1997) that under H 0 , the statistic 2 log z asymptotically has a χ 2 1 distribution and therefore the threshold z α can be easily obtained from P r(z > z α ) = α, as n, m → ∞. Moreover, this test is asymptotically most powerful (e.g. Choi et al, 1996) .
Test Based on Data Subject to Limit of Detection
If measurements of the biomarkers are subject to a limit of detection, then instead of observing x 1i , x 2i , y 1j , y 2j we have
where k = 1, 2, i = 1, . . . , n, j = 1, . . . , m and d x , d y are the values of the LOD (e.g. Lynn, 2001; Lubin et al, 2004; Schisterman et al, 2006; Vexler et al, 2006; Mumford et al, 2006) . In the present paper we assume, without loss of 
, respectively, that are formally defined in Appendix A.
Thus the MLRT statistic is given by
Subsequently, the test threshold z α can be obtained by the MLRT's asymptotic result: 2 log z without using closed forms of the estimators of the unknown parameters. A schematic example of programming in R is available upon request from the first author.
Remark 2: Transformed normal approach. The proposed method is based on the MLRT technique and hence the parametric assumptions regarding the data points are required. In order to relax the normal distribution assumptions, following Molodianovitch et al. (2006) we can fit the data to a Box-Cox power transformation model to better achieve normality and then test for (1). Note that, Molodianovitch et al. (2006) have concluded that the transformed normal approach is efficient and robust when AUCs are compared. We present a modification of the proposed test in Appendix B.
Simulation
We conducted Monte Carlo simulations to examine the performance of the proposed method. To this end, we generated values of {x 1i , i = 1, . . . , n} from the normal distribution with mean µ x 1 and variance 1, and
Similarly, y 1j ∼ N (1, 0. 5 2 ) and y 2j = by 1j + ε j (j = 1, . . . , m) were generated.
1/2 , where a and b are specified below.
Significance Level of the Test. Setting a = 0.7, b = 0.5, µ x 1 = 1.274,
we have AU C 1 = AU C 2 = 0.597. For each value of d = −3, -1, -0.5, 0, 0.5, and 0.75 we generated 10,000 samples of {x 1i , x 2i , i = 1, . . . , n} and {y 1j , y 2j , j = 1, . . . , m}. Based on the generated samples, in each repetition we calculated the values of the test-statistic z (LOD) .
[ [ Table 2 Robustness. The simulations thus far assume that the samples follow normal distributions. In order to illustrate the robustness of our method, we performed the following Monte Carlo simulations. Suppose that, instead of following normal distributions, the diagnostic markers satisfy x 2i = 0.7x
, y 2j = 0.3y
, where x Table 3 corresponds to the case when we expect for the Type I error to be 0.05 (the test threshold 2 log z α is 3.84).
[ Table 3 about here.]
From these results we conclude that the proposed method is reasonable even when the distributional assumptions do not exactly satisfy normality. However, the accuracy of the expected significance level is poor when d = 0
(about 50% of the data are below the detection limit). In contrast, Table 1 indicates that under the corrected distributional assumption this proportion of observations below LOD is not critical. 
[ 
Examples
We exemplify the proposed method with data from the two studies briefly described in the introduction.
The IQ Study
Here we examine whether biomarker IL8 has the ability to discriminate be- 
= 0.57. Now, we test for AU C = 0.5 under the ROC curve of IL8 (i.e. no discriminatory ability of the biomarker). This is a particular case of the testing procedure considered in Section 2. Specifically, since the AU C = 0.5 iff E log X = E log Y , the test statistic has the form 2 log z = 2 sup µx,µy,σx,σy Although standard SPSS output gives the asymptotic 95% confidence interval (CI) of AU C 1 as (0.628,0.708) and of AU C 2 as (0.481,0.585), in the simple case where d = 0, we can not conclude that H 0 : AU C 1 = AU C 2 is rejected because the estimators of AU C 1 and AU C 2 are correlated. We utilize a method proposed by Wieand et al. (1989, p. 587) . Following these authors, we have, if biomarkers' values are normally distributed, the test-statistic
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Thus, since the z CI calculated from the data is 4.71, the p − value of the test | z CI |> z α is 0.0021, whereas our proposed method has p-value 10.20 × 10 −7 ; see Table 5 (d = 0).
Discussion
In the present article, we have shown that the maximum likelihood ratio approach serves as a method of testing for the hypothesis regarding the comparison of AUCs. Such an approach yields a powerful test with characteristics that can be obtained by the well-established maximum likelihood theory. We used real data examples to illustrate how easily MLRT method can be carried out in order to compare two biomarkers and to determine whether a biomarker has discriminatory ability.
The paper assumes normal distributions for the values of the biomarkers when LOD is present. However, the proposed approach can be extended to other commonly used distributions, e.g., gamma, lognormal, etc. Similarly, we can perform hypothesis testing for AUCs based on right, double censored, or truncated data. We have focused on comparing paired correlated areas, but the proposed method can be adapted to multivariate cases as well.
Our paper presented a method dealing with data subject to LOD with broad validity under a reasonable set of assumptions. Sensitivity analysis, though beyond the scope of the present paper, is important to assess these distributional assumptions. This topic can be discussed in a general context of missing data analysis; see Molenberghs and Kenward (2007) . However, one must bear in mind that data below LOD are informative missing, in the sense that they are unobservable only if the actual values are below the detection limit.
We briefly investigated several imputation methods that are commonly applied among epidemiologists in dealing with LOD data. These methods, however, are not statistically justified and should not be confused with the popular method of multiple imputation (e.g. Rubin, 1987) in the missing data analysis literature. The use of multiple imputation in the analysis of LOD data deserves further investigation.
Note that nonparametric distribution function estimation based on censored data can be obtained and hence Kolmogorov-Smirnov (or ShapiroWilk) -type tests for correctness of parametric assumptions can be evaluated (e.g., Verrill and Johnson, 1988) . In the context of the ROC curves and BoxCox power transformation models based on data subject to LOD, we will address nonparametric and semi parametric methods in a subsequent article.
The proposed approach preserves the efficiency of the MLRT when applied to testing for biomarkers' diagnostic accuracy subject to the limit of detection. When an additive measurement error is in effect, the appropriate maximum likelihood approach can also be utilized following method similar to that of Section 2. matches t (x) i3 ). Finally, when both x 1 and x 2 are not observed numerically, we have t (x) 4 (i.e. t (x) 4 represents the probability of both x 1 and x 2 to be NA). The likelihood function based on Y = {y 1j , y 2j } m j=1 is defined in a similar manner:
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